|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1989-7-25
|
|
pubmed:abstractText |
The hypothesis that abnormal fibronectin metabolism in Crohn's disease could be an important mechanism leading to stricture formation or postoperative infection was tested in three related studies. (1) Lower concentrations of plasma fibronectin (p less than 0.05) were found in 20 patients with small and large bowel Crohn's disease (mean 0.24 g/l) compared with 13 patients with more limited disease confined to only small or only large bowel (mean 0.27 g/l) or 20 healthy controls (mean 0.29 g/l). (2) In 25 patients followed for 10 days after operation for Crohn's disease, there was a significant fall in fibronectin concentrations of 43% (p less than 0.01, Wilcoxon's rank-sum test). This fall was maximal on the second postoperative day and was more marked in patients undergoing more major operative procedures. (3) The predictive value of plasma fibronectin for subsequent stricture formation or progression was studied for one year; during which 10 patients developed strictures requiring operative treatment. Higher plasma fibronectin concentrations were related to stricture formation, although there was not a complete, predictive relationship. In this study we found that plasma fibronectin concentrations were low in patients with extensive or severe Crohn's disease, fall after operation and may be related to the risk of stricture formation. This relationship is unlikely to be of clinical value, although it shows the potential significance of fibronectin in the pathogenesis of strictures.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/2731755-13316140,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2731755-19499,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2731755-357987,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2731755-3663579,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2731755-3943280,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2731755-3967133,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2731755-6102236,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2731755-6468201,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2731755-6478167,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2731755-675246,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2731755-6768291,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2731755-6830338,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2731755-686878,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2731755-6973509,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2731755-6994838,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2731755-7049547,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2731755-7056032,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2731755-7104486,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2731755-7120630,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2731755-7136938,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2731755-7264318,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2731755-7359083,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2731755-7447165
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0017-5749
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
30
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
627-33
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
|
|
pubmed:year |
1989
|
|
pubmed:articleTitle |
Plasma fibronectin in Crohn's disease.
|
|
pubmed:affiliation |
General Hospital, Rheumatism Research Wing, Birmingham University, London.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
